Intelligent Bio Solutions Inc. Advances U.S. Market Expansion with Portable Drug Testing System

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is setting a new standard in drug testing technology with its portable Intelligent Fingerprint Drug Screening System. This innovative system utilizes fingerprint sweat to screen for a range of substances, including cannabis, cocaine, methamphetamine, and opiates, delivering results in under ten minutes. Such rapid testing capabilities are poised to transform on-site decision-making processes in critical sectors such as healthcare, justice, and workplace safety.

The significance of this technology cannot be overstated, especially in the context of the ongoing opioid crisis and the increasing legalization of cannabis in various U.S. states. The ability to quickly and non-invasively test for drug use has profound implications for addiction treatment programs, criminal justice systems, and employers striving to maintain safe work environments. By providing immediate results, the system enables faster interventions, potentially saving lives and reducing the societal costs associated with drug abuse.

Currently operating in a Forensic Use Only capacity in the U.S., INBS is actively pursuing FDA approval to broaden its market reach. The company's participation in the RISE25 conference, a key gathering for professionals in addiction treatment, mental health, and criminal justice, underscores its commitment to expanding its footprint in the U.S. market. With over 450 active accounts across 24 countries, INBS is well-positioned to make a significant impact on global drug screening practices.

The partnership with SMARTOX, a U.S. distributor, further facilitates INBS's engagement with stakeholders in the criminal justice and addiction recovery sectors. This collaboration highlights the growing demand for efficient and reliable drug testing solutions that can keep pace with the challenges of modern society. As INBS continues to advance its technology and regulatory approvals, the potential for its fingerprint drug screening system to become a cornerstone of drug detection efforts worldwide is increasingly evident.